Abstracts & Presentations
International Conferences
2018 International Conferences
(By conference, by month, by author)
Advances in Respiratory Virus Therapeutics, the 6th ISIRV (International
Society for Influenza and Other Respiratory Virus Diseases) AVG (Antiviral
Group) Conference, Washington DC, November 2018
INSIGHT FLU-IVIG Study Group (Davey RT, presenting), INSIGHT FLU-IVIG
(FLU-006): A randomized, placebo controlled trial of influenza
immunoglobulin in the treatment of adults hospitalized with influenza -
Abstract |
Slides
IDWeek 2018, San Francisco, California, October 2018
Ekenberg C et al, Study of single nucleotide polymorphisms associated with
HIV-1 set-point viral load in antiretroviral therapy-naïve HIV-positive
participants of the START study -
Abstract |
Poster
AIDS 2018, Amsterdam, the Netherlands, July 2018
Castillo-Mancilla J et al, Incomplete ART adherence is associated with
higher interleukin-6 in individuals with HIV who achieved virologic
suppression in the immediate arm of the Strategic Timing of Antiretroviral
Treatment (START) study -
Abstract |
Poster
ATS (American Thoracic Society) 2018, San Diego, California, May 2018
Kunisaki KM et al, Pulmonary effects of immediate versus deferred
antiretroviral treatment initiation: Final follow-up results from the
randomized Strategic Timing of Antiretroviral Treatment (START) Pulmonary
Substudy -
Abstract |
Poster
Leung JM et al, Methylation patterns of lung function decline in Human
Immunodeficiency Virus -
Abstract |
Poster
Serrano C et al, Lung function decline and CD4+ T-cell counts at ART
initiation in the START trial -
Abstract |
Poster
22nd International Workshop on HIV and Hepatitis Observational Databases,
Fuengirola, Spain, March 2018
Lodi S, Effect estimates of randomized trials and observational studies:
comparing apples with apples --
Abstract |
Poster
CROI 2018 (Conference on Retroviruses and Opportunistic Infections),
Boston, Massachusetts, March 2018
Baker JV et al, IL-6, D-dimer or T-cells: which best predict events or
explain benefits of early ART? -
Abstract |
Slides
Baxter JD et al, Pretreatment HIV drug resistance in the START study using
next generation sequencing -
Abstract |
Poster
Carr A et al, Rates of bone loss slow after the first year of ART: START BMD
Substudy final results -
Abstract |
Poster
MacDonald D et al, Smoking and accelerated lung function decline in the
START Pulmonary Substudy -
Abstract |
Poster
Peterson T et al, Inflammation associates with impaired arterial elasticity
in early HIV disease -
Abstract |
Poster
